1. Qiu, J. Human parvoviruses / J. Qiu, M. Söderlund-Venermo, N. S. Young // Clin. Microbiol. Rev. – 2017. – Vol. 30, N 1. – P. 43–113.

2. Genetic diversity within human erythroviruses: identifcation of three genotypes / A. Servant [et al.] // J. Virol. – 2002. – Vol. 76, N 18. – P. 9124–9134. https://doi.org/10.1128/jvi.76.18.9124-9134.2002

3. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients / N. Toan [et al.] // J. Gen. Virol. – 2006. – Vol. 87, N 10. – P. 2941–2949. https://doi.org/10.1099/vir.0.82037-0

4. Identifcation and genetic diversity of two human parvovirus B19 genotype 3 subtypes / A. Parsyan [et al.] // J. Gen. Virol. – 2007. – Vol. 88, pt. 2. – P. 428–431. https://doi.org/10.1099/vir.0.82496-0

5. Identifcation and characterization of persistent human erythrovirus infection in blood donor samples / D. Candotti [et al.] // J. Virol. – 2004. – Vol. 78, N 22. – P. 12169–12178. https://doi.org/10.1128/jvi.78.22.12169-12178.2004

6. Cohen, B. Genetic variants of parvovirus B19 identifed in the United Kingdom: implications for diagnostic testing / B. Cohen, J. Gandhi, J. Clewley // Clin. Virol. – 2006. – Vol. 36, N 2. – P. 152–155. https://doi.org/10.1016/j.jcv.2006.01.011

7. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests / K. Hokynar [et al.] // J. Clin. Microbiol. – 2004. – Vol. 42, N 5. – P. 2013–2019. https://doi.org/10.1128/jcm.42.5.2013-2019.2004

8. Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confrms the predominance of genotype 1 and suggests the spread of genotype 3b / J. Hubschen [et al.] // J. Clin. Microbiol. – 2009. – Vol. 47, N 11. – P. 3735–3738. https://doi.org/10.1128/jcm.01201-09

9. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms / S. Sanabani [et al.] // J. Clin. Microbiol. – 2006. – Vol. 44, N 2. – P. 604–606. https://doi.org/10.1128/jcm.44.2.604-606.2006

10. Nicolay, N. Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996–June 2008 / N. Nicolay, S. Cotter // Eurosurveillance. – 2009. – Vol. 14, N 25. – P. 7–11.

11. Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identifcation of a novel subtype of genotype 1 / C. Corcoran [et al.] // J. Clin. Microbiol. – 2010. – Vol. 48, N 1. – P. 137–142. https://doi.org/10.1128/jcm.00610-09

12. Identifcation and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland / P. Grabarczyk [et al.] // J. Med .Virol. – 2010. – Vol. 83, N 1. – P. 142–149. https://doi.org/10.1002/jmv.21947

13. Генотипирование изолятов парвовируса В19, циркулирующих в Северо-Западном федеральном округе России / И. Н. Лаврентьева [и др.] // Журн. микробиологии, эпидемиологии и иммунобиологии. – 2013. – № 6. – C. 36–43.

14. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities / A. C. da Costa [et al.] // Clin. Microbiol. Infect. – 2013. – Vol. 19, N 1. – P. E31–E43. https://doi.org/10.1111/1469-0691.12058

15. Prevalence and genotypic characterization of human parvovirus B19 in children with measles- and rubella-like illness in Iran / F. Rezaei [et al.] // J. Med. Virol. – 2015. – Vol. 88, N 6. – P. 947–953. https://doi.org/10.1002/jmv.24425

16. Genotype 1 of human parvovirus B19 in clinical cases / M. I. de Oliveira [et al.] // Rev. Assoc. Med. Bras. – 2017. – Vol. 63, N 3. – P. 224–228. https://doi.org/10.1590/1806-9282.63.03.224

17. Young, N. Parvovirus B19 / N. S. Young, K. E. Brown // N. Engl. J. Med. – 2004. – Vol. 350, N 6. – P. 586–597. https://doi.org/10.1056/nejmra030840

18. Динамика эпидемического процесса парвовирусной инфекции в Республике Беларусь (2005–2016) / М. А. Ермолович [и др.] // Журн. Гродн. гос. мед. ун-та. – 2017. – Т. 15, № 4. – C. 414–417.

19. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods / K. Tamura [et al.] // Mol. Biol. Evol. – 2011. – Vol. 28, N 10. – P. 2731–2739. https://doi.org/10.1093/molbev/msr121

20. Human parvovirus B19 surveilance in patients with rash and fever from Belarus / M. Yermalovich [et al.] // J. Med. Virol. – 2012. – Vol. 84, N 6. – P. 973–978. https://doi.org/10.1002/jmv.23294

21. Umene, K. Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognizing four or fve base pairs and partial nucleotide sequencing: use of sequence variability in virus classifcation / K. Umene, T. Nunoue // J. Gen. Virol. – 1991. – Vol. 72, N 8. – P. 1997–2001. https://doi.org/10.1099/0022-1317-72-8-1997

22. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil / R. Freitas [et al.] // J. Clin. Virol. – 2008. – Vol. 43, N 1. – P. 60–65. https://doi.org/10.1016/j.jcv.2008.03.033

23. Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions / M. W. A. Molenaar-de Backer [et al.] // PLoS ONE. – 2012. – Vol. 7, N 8. – P. e43206. https://doi.org/10.1371/journal.pone.0043206

24. Molecular diversity of human parvovirus B19 during two outbreaks of erythema infectiosum in Brazil / R. Cubel Garcia [et al.] // Braz. J. Infect. Dis. – 2017. – Vol. 21, N 1. – P. 102–106. https://doi.org/10.1016/j.bjid.2016.11.002

25. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors / S. Slavov [et al.] // J. Med. Virol. – 2012. – Vol. 84, N 10. – P. 1652–1665. https://doi.org/10.1002/jmv.23358